TB Alliance

TB Alliance, also known as the Global Alliance for TB Drug Development, is a non-profit organization that operates as a 501(c)(3) legal entity. Established in 2000 and headquartered in New York City, the organization is based in the United States. The CEO of TB Alliance is Melvin Spigelman.

The primary focus of TB Alliance is the development of new and improved treatments for tuberculosis. The organization has a full address of 40 Wall Street, 24th Floor, New York, NY 10005, US. TB Alliance employs between 50 to 99 people, working together under the legal form of a 501(c)(3) organization.